AEGiS-NIH: NIDA Meeting to Look at Drug-Impaired Decision-Making and HIV Transmission: One of First-Ever NIH Meetings to Examine the Role between Non-Injection Drug Use and HIV/AIDS

Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.

NIDA Meeting to Look at Drug-Impaired Decision-Making and HIV Transmission: One of First-Ever NIH Meetings to Examine the Role between Non-Injection Drug Use and HIV/AIDS

National Institutes Of Health - April 4, 2007
CONTACT: Dorie Hightower or Sara Rosario Wilson, 301-443-6245

The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), is holding a two day meeting to explore wide-ranging issues related to drug abuse, impaired decision making, and HIV/AIDS. Drug Abuse and Risky Behaviors: The Evolving Dynamics of HIV/AIDS will provide a broad understanding of the multiple ways that drug abuse and addiction affect the spread of HIV/AIDS and how research can inform public health policy. Presentations will focus on the successes, research challenges, and opportunities for addressing the evolving HIV/AIDS pandemic. Attendees will be drawn from the research community, public health organizations, Federal agencies, and drug abuse and HIV/AIDS organizations.

Drug abuse and addiction continue to fuel the spread of HIV/AIDS in the United States and abroad. To address this significant public health threat, research is examining every aspect of HIV/AIDS, drug abuse, and addiction, including risk behaviors associated with both injection and non-injection drug abuse, how drugs of abuse alter brain function and impair decision making, and HIV prevention and treatment strategies for diverse groups. The meeting is being held in collaboration with the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute on Child Health and Human Development (NICHD), and the National Institute of Mental Health (NIMH).

What: Drug Abuse and Risky Behaviors: The Evolving Dynamics of HIV/AIDS.

When:

Tuesday, May 8, 2007
8:15 a.m. - 4:30 p.m.

Wednesday, May 9, 2007
8:30 a.m. - 12:15 p.m.

Where:

Natcher Conference Center
National Institutes of Health
9000 Rockville Pike
Bethesda, MD 20892

Who: Featured Speakers

Dr. Nora D. Volkow, Director
NIDA Dr. Anthony S. Fauci, Director, NIAID

Info: Topics that will be covered include, but are not limited to, the following:

How drugs of abuse alter brain function, leading to impaired decision making and risky behaviors, which in turn can facilitate the acquisition and transmission of HIV;
How and to what extent substance abuse influences sexual risk behaviors;
How substance abuse affects HIV/AIDS risk in diverse populations (e.g., adolescents, minorities, those involved with the criminal justice system); and
How testing and counseling can be incorporated as a key component of HIV prevention strategies for drug-abusing populations.

A full agenda and speaker list is available at: http://conferences.masimax.com/riskybehaviors/agenda.cfm

The National Institute on Drug Abuse is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world's research on the health aspects of drug abuse and addiction. The Institute carries out a large variety of programs to ensure the rapid dissemination of research information and its implementation in policy and practice. Fact sheets on the health effects of drugs of abuse and information on NIDA research and other activities can be found on the NIDA home page at www.drugabuse.gov.

The National Institutes of Health (NIH) - The Nation's Medical Research Agency - includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov

070404
NIH070401

Published 2007 - The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the primary Federal agency for conducting and supporting medical research. All material contained in this report is in the public domain and may be used and reprinted without special permission; citation to source, however, is appreciated.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .